| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |